Healthcare Services

Opioid Use Disorder (OUD) Market Insights Exploring Expansion Opportunities Through 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Opioid Use Disorder (OUD) Market Become By 2030 Compared To 2026?

The opioid use disorder (oud) market has experienced rapid expansion in recent years. This market is projected to grow from $4.37 billion in 2025 to $4.89 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. The historical growth can be attributed to several factors, including the widespread overprescription of opioid painkillers, an increasing prevalence of chronic pain conditions, limited access to early addiction treatment, the social stigma surrounding substance abuse treatment, and the growing availability of illicit opioids.

The market for opioid use disorder (OUD) is projected to experience substantial growth in the upcoming years, with an anticipated value of $7.82 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This expansion during the forecast period is fueled by several factors, including increased government investment in addiction treatment initiatives, wider embrace of medication-assisted treatment, the proliferation of online and telehealth services for addiction, broader insurance coverage for OUD treatments, and a greater emphasis on preventive measures and harm reduction approaches. Key trends foreseen over this period involve the growing implementation of medication-assisted treatment programs, enhanced integration of behavioral therapy with pharmaceutical care, the expanding network of community-based opioid treatment facilities, a heightened focus on long-acting injectable OUD therapies, and a stronger emphasis on preventing relapses and ensuring long-term recovery support.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Growth Drivers Are Expected To Support The Opioid Use Disorder (OUD) Market Forward?

The increasing number of opioid addiction cases is anticipated to drive the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction is a medical condition defined by the compulsive and chronic consumption of opioids, which leads to detrimental effects on the body. Opioids offer sensations of euphoria and pain relief, but their persistent use can result in tolerance, where greater doses are needed to achieve the desired effect, potentially leading to opioid use disorder. For instance, in 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, the number of drug overdose deaths involving any opioid was 79,358. This figure represents 23.7 drug overdose deaths involving any opioid per 100,000 population. Consequently, the rising prevalence of opioid addiction cases fuels the growth of the opioid use disorder (OUD) market.

Which Segment-Based Categories Are Covered In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route Of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Which Trends Are Supporting The Evolution Of The Opioid Use Disorder (OUD) Market?

Which Organizations Are Involved In The Opioid Use Disorder (OUD) Market?

Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics

Access The Complete Opioid Use Disorder (OUD) Market Report:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Which Region Commands The Largest Share Of The Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Opioid Use Disorder (OUD) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2026, By The Business Research Company

Ophthalmic Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-global-market-report

Ophthalmology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/ophthalmology-drugs-market

Ophthalmic Eye Dropper Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ophthalmic-eye-dropper-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795